Recent Event
Benzinga Cannabis Capital Conference
Company Overview
Skye Bioscience Inc. is a biopharmaceutical company focused on the development of proprietary, synthetic cannabinoid derived molecules for the treatment of diseases with significant unmet needs. The company’s lead molecule, in preclinical studies, has demonstrated potential as a new class of therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to currently available drugs.
IR Contacts
Company
Skye Bioscience, Inc.
5910 Pacific Center Blvd.
Suite 320
San Diego, CA 92121
Investor Relations
SKYE Investor Relations
T: 949-396-0330
ir@skyebioscience.com
Transfer Agent
ClearTrust, LLC
16540 Pointe Village Dr.
Suite 210
Lutz, FL 33558
T: 813-235-4490
www.ClearTrustOnline.com
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.